Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (20 ops.)
Latest filing published 01 Oct 2026 for RESMED INC. Read the official filing
Filing timeline
BuySaleMichael J. Rider
Insider track record
Disclosed buys
0
Disclosed sells
20
Signal history
Michael J. Rider: trading record in brief
This profile gathers the share dealings of Michael J. Rider in ResMed Inc. Over a trading history stretching from 3 July 2023 to 14 August 2026, the count stands at 30 filings.
No open-market purchase appears, only 20 sales worth €415k. Other entries cover 8 share grants. In 2026 alone, the filings show no purchases and 2 sales.
The latest filing, published on 1 October 2026, reports a share grant in ResMed Inc. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Michael J. Rider
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations30 total
3,230 shares0ResMed Common StockSEC:0000943819-26-000076:0
50 shares@ US$260.001.6% of flowResMed Common StockSEC:0000943819-26-000009:0
50 shares@ US$241.751.5% of flowResMed Common StockSEC:0000943819-26-000001:0
50 shares@ US$244.161.6% of flowResMed Common StockSEC:0000943819-25-000185:0
135.075 shares@ US$250.104.4% of flowResMed Common StockSEC:0000943819-25-000096:0
100 shares@ US$274.363.5% of flowResMed Common StockSEC:0000943819-25-000080:0
2,941 shares0ResMed Common StockSEC:0001127602-25-020652:0
50 shares@ US$281.901.8% of flowResMed Common StockSEC:0000943819-25-000030:0
66 shares@ US$256.992.1% of flowResMed Common StockSEC:0000943819-25-000024:0
41 shares@ US$243.781.3% of flowResMed Common StockSEC:0001127602-25-016359:0
64 shares@ US$222.862.0% of flowResMed Common StockSEC:0001127602-25-011320:0
64 shares@ US$234.102.2% of flowResMed Common StockSEC:0001127602-25-007943:0
64 shares@ US$242.422.3% of flowResMed Common StockSEC:0001127602-25-002880:0
75 shares@ US$230.992.5% of flowResMed Common StockSEC:0001127602-25-000486:0
173 shares0ResMed Common StockSEC:0001127602-24-028324:0
684.979 shares@ US$252.3824.1% of flowResMed Common StockSEC:0001127602-24-027092:0
69 shares@ US$242.002.3% of flowResMed Common StockSEC:0001127602-24-026442:0
882 shares@ US$231.0027.4% of flowResMed Common StockSEC:0001127602-24-022691:0
4,474 shares0ResMed Common StockSEC:0001127602-24-022302:0
267.244 shares@ US$206.337.6% of flowResMed Common StockSEC:0001127602-24-018237:0
81 shares@ US$180.002.0% of flowResMed Common StockSEC:0001127602-24-008924:0
200 shares@ US$173.254.8% of flowResMed Common StockSEC:0001127602-24-008301:0
72 shares0ResMed Common StockSEC:0001127602-23-028288:0
91.637 shares@ US$143.601.8% of flowResMed Common StockSEC:0001127602-23-027469:0
25 shares@ US$143.420.5% of flowResMed Common StockSEC:0001127602-23-026700:0
25 of 30 declarations
